أرسل هذا في رسالة قصيرة: Response rate and progression-free survival in locally advanced or metastatic primary lung adenocarcinoma treated with gefitinib /
Services hosted by the Perpustakaan Sultan Abdul Samad, Universiti Putra Malaysia with Cooperation MySyL Group
